Energinet Cancels DKK 21 million Data Centre Cable Framework Due to Q&A Error
13 Aug 2026
Energinet has cancelled a two-lot framework agreement for data centre cables valued at up to DKK 21 million after discovering an error in one of the Q&A responses. The procurement, which received five bids, will be re-tendered on a revised basis. The cancellation affects both patch cables (Lot 1) and power cables (Lot 2). Introduction Reliable cabling infrastructure is essential for the operation of data centres and critical IT systems. Energinet, the Danish transmission system operator for electricity and gas, sought to establish a framework agreement for the supply of patch cables and power cables for its data centres. However, the procurement has been cancelled after Energinet discovered an error in one of the responses provided during the Q&A process. The framework, which had received five bids, will be re-tendered on a revised basis. The cancellation affects both Lots: patch cables (estimated DKK 8 million) and power cables (estimated DKK 3 million). This cancellation highlights the importance of accuracy and transparency in public procurement, particularly in complex technical specifications. Why This Contract Mattered Data centre cabling is critical for reliable IT operations. Energinet's framework would have ensured a stable supply of high-quality patch cables and power cables for its data centres over an eight-year period. This contract mattered because it: Supported critical infrastructure: Cables for Energinet's data centres Long-term supply: 8-year framework Significant value: Up to DKK 21 million Quality testing: Product samples evaluated against technical criteria Balanced evaluation: Price (70%) and Quality (30%) Transparent process: Clear technical testing criteria Market interest: Five bids received Contract Timeline Contract award notice published: 13 August 2026 (OJ S 155/2026) Previous notice referenced: 461045-2026 Planned start date: 15 August 2026 Outcome: Cancelled due to Q&A error Contract Overview Energinet conducted an open procedure for this procurement under the EU Sector Directive (Directive 2014/25/EU). The framework covered the supply of patch cables (Lot 1) and power cables (Lot 2) for data centres. Key features included: Two lots: Lot 1 (Patch cables), Lot 2 (Power cables) Estimated value: DKK 11,000,000 (up to DKK 21,000,000 maximum) Duration: 8 years (starting 15 August 2026) Evaluation: Price (70%) and Quality (30%) Quality testing: Product samples tested against technical criteria Framework type: Without reopening of competition Key Contract Details Detail Information Contracting authority Energinet Contract subject Data centre cables (CPV 32420000, 32421000, 31321000) Procedure type Open procedure (Sector Directive) Legal basis EU Directive 2014/25/EU Total estimated value (DKK) DKK 11,000,000.00 Total maximum value (DKK) DKK 21,000,000.00 Lot 1 estimated value DKK 8,000,000 (max DKK 15,000,000) Lot 2 estimated value DKK 3,000,000 (max DKK 6,000,000) Contract duration 8 Years Bids received 5 per lot EU funding None Covered by GPA Yes Evaluation criteria Price (70%), Quality (30%) Outcome Cancelled – error in Q&A process Project Scope The framework was intended to cover the supply of data centre cables across two lots: Lot 1: Patch Cables Description: Network patch cables for data centre connections Estimated value: DKK 8,000,000 Maximum value: DKK 15,000,000 Quality testing: Fiber locking mechanism (40%), Fiber polarity (40%), PDS locking mechanism (20%) Lot 2: Power Cables Description: Power cables for data centre equipment Estimated value: DKK 3,000,000 Maximum value: DKK 6,000,000 Quality testing: Locking mechanism retention (33%), Locking mechanism release (33%), Accessibility to locking mechanism (34%) Quality Evaluation Method: Product samples tested against technical criteria Scoring: 0-10 scale (10 is best) Pass mark: Minimum total score of 5 points About the Contracting Authority Energinet is the Danish transmission system operator for electricity and natural gas. It is a public undertaking responsible for the operation and development of Denmark's energy infrastructure, including the electricity grid and gas network. Energinet's data centres support critical energy system operations. About the Winning Company No contract was awarded. The procurement was cancelled due to an error in the Q&A process. Energinet will re-tender the framework on a revised basis. No winning company exists for this procurement. Reasons for Cancellation Energinet cancelled the procurement due to an error in one of the responses provided during the Q&A process. The cancellation reasons include: Q&A error: An error was identified in one of the responses provided to bidders Transparency concerns: Energinet determined that cancellation was the most appropriate course of action to ensure transparency Revised basis: The procurement will be re-tendered on a revised basis No bids awarded: No contract was awarded under the cancelled procedure Additional Procurement Facts The contract is covered by the WTO's Government Procurement Agreement (GPA). No EU funds were used for this procurement. The procurement was not accelerated. No dynamic purchasing system was used. No framework agreement was awarded. Five bids were received for each lot. All bids were submitted electronically. Two of five bidders were SMEs. No bids were received from outside Denmark (0 from other EEA countries). Disputes or review requests fall to Klagenævnet for Udbud. Energinet expects to re-tender the contract in revised form. Market & Industry Perspective The market for data centre cabling is competitive, with a mix of large international manufacturers and specialist suppliers. Public sector procurements for cabling often attract strong interest from both large and small suppliers. Key trends in this market include: Quality focus: Technical quality and performance are critical Product testing: Buyers increasingly test product samples Long-term contracts: 8-year frameworks provide stability SME participation: SMEs can compete effectively Transparency: Accurate Q&A responses are essential The five bids received per lot indicate strong market interest. The cancellation, while unfortunate, demonstrates Energinet's commitment to transparency and fair competition. Economic Significance At up to DKK 21 million, this framework represented a significant procurement for data centre cabling. The cancellation means that Energinet will need to re-tender the contract, potentially delaying the supply of cables for its data centres. For the five bidders, the cancellation represents a missed opportunity, though the planned re-tender offers a second chance. Future Procurement Opportunities With the procurement now cancelled, future opportunities include: Re-tender: Energinet expects to re-tender the contract in revised form Adjusted specifications: The re-tender may feature revised requirements Other Energinet procurements: Energinet conducts many other procurements Other Danish public bodies: Similar cabling frameworks by other Danish public bodies Opportunities for Suppliers While this procurement is cancelled, future opportunities exist for cabling suppliers: Re-tender: Prepare for the re-tender on a revised basis Engage with Energinet: Provide feedback on the specifications Quality products: Ensure product samples meet technical criteria Competitive pricing: Price accounts for 70% of evaluation Other Danish public bodies: Similar cabling frameworks What Businesses Should Watch Re-tendering of this framework by Energinet Revised specifications in the re-tender Other Energinet procurement notices Similar cabling tenders from other Danish public bodies Changes to Energinet's data centre requirements DenmarkTenders Procurement Intelligence This cancelled procurement highlights several important lessons for public procurement: Accuracy matters: Q&A responses must be accurate and consistent Transparency is essential: Cancelling a flawed procedure protects integrity Re-tendering is common: Errors in procurement are sometimes unavoidable Market interest: Five bidders indicate strong market interest For suppliers, this cancellation presents an opportunity to: Provide feedback: Engage with Energinet to help shape the re-tender Prepare for re-tender: Ensure product samples and pricing are competitive Monitor notices: Watch for the revised tender announcement Supplier Takeaways Prepare for the re-tender—it is expected in revised form Engage with Energinet to provide feedback on specifications Ensure product samples meet technical criteria—quality accounts for 30% Offer competitive pricing—price accounts for 70% Monitor Energinet's procurement portal for the re-tender announcement Consider SME status as a potential advantage Key Takeaways Energinet cancelled a DKK 21 million data centre cable framework due to a Q&A error 2 lots: Patch cables (DKK 8M estimated) and Power cables (DKK 3M estimated) 5 bids received per lot Evaluation: Price (70%), Quality (30%) Quality testing: Product samples assessed against technical criteria Duration: 8 years (planned start 15 August 2026) Re-tender expected in revised form All bidders from Denmark (0 from other EEA countries) Conclusion The cancellation of this data centre cable framework represents a setback for Energinet's procurement plans, but it also demonstrates the organisation's commitment to transparency and fair competition. By cancelling the procedure and committing to a re-tender, Energinet ensures that all potential suppliers have an equal opportunity to compete. The five bids received indicate strong market interest in the framework. Suppliers should prepare for the re-tender, ensuring that their product samples meet the technical criteria and that their pricing is competitive. As Energinet continues to operate and develop Denmark's energy infrastructure, this framework will be essential for ensuring the reliable supply of data centre cabling. Frequently Asked Questions Q: What is Energinet? Ans: The Danish transmission system operator for electricity and natural gas, responsible for the operation and development of Denmark's energy infrastructure. Q: What was the value of the framework? Ans: Estimated DKK 11,000,000 (up to DKK 21,000,000 maximum). Q: How many bids were received? Ans: Five bids were received for each lot. Q: Why was the procurement cancelled? Ans: Due to an error in one of the responses provided during the Q&A process. Q: Will the contract be re-tendered? Ans: Yes, Energinet expects to re-tender the contract on a revised basis. Q: What were the lots? Ans: Lot 1 (Patch cables) and Lot 2 (Power cables). Q: What were the evaluation criteria? Ans: Price (70%) and Quality (30%). Q: Is this contract funded by the EU? Ans: No, the procurement is not financed with EU funds. Source: EU Official Journal, Contract Award Notice 561344-2026, OJ S 155/2026, published 13 August 2026. body { font-family: sans-serif; margin: 20px; } table { border-collapse: collapse; width: 100%; margin: 15px 0; } th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; } th { background-color: #f2f2f2; } ul { padding-left: 20px; } h2 { margin-top: 30px; } h3 { margin-top: 20px; }
View Details
Amgros Awards DKK 690 Million Pharmaceutical Framework
12 Aug 2026
Amgros I/S has awarded a DKK 690 million framework agreement for pharmaceutical products to multiple suppliers including FrostPharma AB, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, and Devatis GmbH. The four-lot framework covers Bortezomib, Thalidomid, Lenalidomid, and Pomalidomid for Danish hospital pharmacies from January 2027. Introduction Ensuring the supply of essential medicines to hospital pharmacies is a critical function of Denmark's healthcare system. Amgros I/S, the central purchasing body for the five Danish regions, conducts competitive procurements to secure cost-effective pharmaceutical products for hospital pharmacies across the country. This framework, valued at up to DKK 690 million (approximately €92.5 million), covers four lots for key pharmaceutical products: Bortezomib (Lot 1), Thalidomid (Lot 2), Lenalidomid (Lot 3), and Pomalidomid (Lot 4). The contracts, running from January 2027, have been awarded to FrostPharma AB, Zentiva Denmark ApS, Sun Pharmaceuticals Germany GmbH, and Devatis GmbH. This procurement ensures that Danish hospital pharmacies have access to essential medicines for cancer treatment and other serious conditions. Why This Contract Matters Cancer treatment relies on a range of essential medicines, including immunomodulatory agents like Lenalidomid and Pomalidomid. This framework ensures the supply of these critical medicines to Danish hospital pharmacies. This contract matters because it: Secures essential medicines: Covers Bortezomib, Thalidomid, Lenalidomid, and Pomalidomid Supports cancer treatment: Medicines for multiple myeloma and other cancers Serves Danish hospitals: Supplies hospital pharmacies across all five regions Significant value: DKK 690 million (approx. €92.5 million) Price-focused: Price-only evaluation (100%) Competitive process: 2-6 bids per lot International suppliers: Winners from Sweden, Denmark, and Germany Contract Timeline Contract award notice published: 12 August 2026 (OJ S 154/2026) Previous notice referenced: 219057-2026 Contract concluded: 11 August 2026 Coverage start date: 1 January 2027 Coverage end date: 31 December 2028 (with 12-month extension option) Contract Overview Amgros I/S conducted an open procedure for this procurement. The framework covers pharmaceutical products across four lots, each representing a separate sub-contract. Key features include: Four lots: Bortezomib, Thalidomid, Lenalidomid, Pomalidomid Total maximum value: DKK 690,479,003 (approx. €92.5 million) Duration: 1 January 2027 – 31 December 2028 (with 12-month extension option) Evaluation: Price only (100%) Framework type: Without reopening of competition Non-exclusive: Hospital pharmacies are not obligated to use the framework Delivery: Nationwide across all Danish regions Key Contract Details Detail Information Contracting authority Amgros I/S Winning bidders FrostPharma AB (Lot 1), Zentiva Denmark ApS (Lot 2), Sun Pharmaceuticals Germany GmbH (Lot 3), Devatis GmbH (Lot 4) Contract subject Pharmaceutical products (CPV 33600000) Procedure type Open procedure Legal basis EU Directive 2014/24/EU Total maximum value (DKK) DKK 690,479,003.00 (approx. €92.5 million) Lot 1 (Bortezomib) value DKK 53,393,487 Lot 2 (Thalidomid) value DKK 1,611,360 Lot 3 (Lenalidomid) value DKK 437,861,613 Lot 4 (Pomalidomid) value DKK 197,612,543 Contract duration 1 Jan 2027 – 31 Dec 2028 (+ 12-month option) EU funding None Covered by GPA Yes Evaluation criteria Price only (100%) Subcontracting No Project Scope The framework covers four pharmaceutical products for Danish hospital pharmacies: Lot 1: Bortezomib (FrostPharma AB) ATC Code: L01XG01 Generic name: Bortezomib Form: Injection solution Strength: 2.5 mg/ml Estimated value: DKK 53,393,487 Units: 16,051 Bids received: 3 Lot 2: Thalidomid (Zentiva Denmark ApS) ATC Code: L04AX02 Generic name: Thalidomid Form: Capsules Strength: 50 mg Estimated value: DKK 1,611,360 Units: 2,492 Bids received: 2 Lot 3: Lenalidomid (Sun Pharmaceuticals Germany GmbH) ATC Code: L04AX04 Generic name: Lenalidomid Form: Capsules Strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg Estimated value: DKK 437,861,613 Units: 287,033 (various strengths) Bids received: 4 Lot 4: Pomalidomid (Devatis GmbH) ATC Code: L04AX06 Generic name: Pomalidomid Form: Capsules Strengths: 1 mg, 2 mg, 3 mg, 4 mg Estimated value: DKK 197,612,543 Units: 43,407 (various strengths) Bids received: 6 About the Contracting Authority Amgros I/S is a Danish joint procurement body (interessentskab) owned by the five Danish regions. Amgros is responsible for purchasing pharmaceuticals and medical equipment for the Danish hospital sector. As a central purchasing body, Amgros negotiates framework agreements that are available to hospital pharmacies across Denmark, as well as for resale to the Faroe Islands and Greenland. The organisation is based in Copenhagen. About the Winning Companies FrostPharma AB (Lot 1 – Bortezomib) FrostPharma AB is a Swedish pharmaceutical company based in Danderyd, Stockholm. The company specialises in the supply of generic and specialty pharmaceuticals. FrostPharma's winning bid of DKK 1,250,000 was the successful tender among three bids received. Zentiva Denmark ApS (Lot 2 – Thalidomid) Zentiva Denmark ApS is a Danish pharmaceutical company based in Frederiksberg, Copenhagen. Zentiva is a leading supplier of generic medicines in Europe. The company won Lot 2 with a bid of DKK 754,000. Sun Pharmaceuticals Germany GmbH (Lot 3 – Lenalidomid) Sun Pharmaceuticals Germany GmbH is a German subsidiary of Sun Pharma, one of the world's largest generic pharmaceutical companies. Based in Leverkusen, the company specialises in oncology and specialty medicines. Sun Pharma's winning bid of DKK 2,100,000 was the successful tender among four bids received. Devatis GmbH (Lot 4 – Pomalidomid) Devatis GmbH is a German pharmaceutical company based in Lörrach, Baden-Württemberg. The company specialises in oncology and specialty pharmaceuticals. Devatis won Lot 4 with a bid of DKK 1,170,000, competing against five other bidders. Procurement Analysis Procedure: An open procedure was used, allowing any interested economic operator to submit a tender. Competition: Competition varied by lot, with 2-6 bids received. Lot 4 (Pomalidomid) attracted the most bids (6). Evaluation criteria: Price only (100%). This is standard for pharmaceutical procurement, where quality is assured through regulatory compliance. International participation: Bids were received from Sweden, Denmark, and Germany, demonstrating the European nature of the pharmaceutical market. SME participation: All bidders were SMEs (micro, small, or medium enterprises), reflecting the structure of the pharmaceutical supply market. Non-exclusive framework: Hospital pharmacies are not obligated to use the framework, providing flexibility. Options: Pre- and post-agreement period options provide flexibility. Additional Procurement Facts The contract is covered by the WTO's Government Procurement Agreement (GPA). No EU funds were used for this procurement. The procurement was not accelerated. No dynamic purchasing system was used. Framework agreements without reopening of competition were used. Bids received from Sweden, Denmark, and Germany. All bidders were SMEs. No subcontracting was declared by any winner. Disputes or review requests fall to Klagenævnet for Udbud (Danish Complaints Board for Procurement). Delivery locations include hospitals and hospital pharmacies across all Danish regions. Market & Industry Perspective The Danish pharmaceutical market is characterised by competitive procurement through Amgros, which leverages the collective buying power of the five Danish regions. The market for oncology pharmaceuticals is particularly competitive, with multiple generic suppliers offering products. Key trends in this market include: Generic competition: Generic versions of oncology drugs provide cost savings Price focus: Price-only evaluation drives competition International suppliers: Suppliers from across Europe compete for Danish contracts SME participation: SMEs dominate the pharmaceutical supply market Centralised procurement: Amgros centralises procurement for efficiency Economic Significance At DKK 690 million (approximately €92.5 million), this framework represents a significant procurement for Danish hospital pharmacies. The contract ensures: Supply security: Essential medicines for cancer treatment are secured Cost efficiency: Competitive procurement drives down costs Patient care: Hospital pharmacies can access essential medicines Regional coverage: All five Danish regions are covered Future Procurement Opportunities With the framework now in place, future opportunities include: Contract extension: 12-month extension option available Re-tender: The framework will be re-tendered for 2029 onwards Other products: Amgros conducts many other pharmaceutical procurements Other European countries: Similar frameworks are conducted by other central purchasing bodies Opportunities for Suppliers While this framework is awarded, future opportunities exist for pharmaceutical companies: Other Amgros tenders: Amgros conducts many other pharmaceutical procurements Other European countries: Similar frameworks by other central purchasing bodies New products: Emerging oncology and specialty medicines Re-tender: The framework will be re-tendered in the future What Businesses Should Watch Amgros' future procurement notices Other European central purchasing bodies' tenders Emerging oncology and specialty medicines Changes to Danish pharmaceutical regulations EU pharmaceutical procurement developments DenmarkTender Procurement Intelligence This pharmaceutical framework is a significant procurement for Danish hospital pharmacies. Several features stand out: Scale: DKK 690 million across four lots Price focus: Price-only evaluation (100%) drives competition International competition: Suppliers from Sweden, Denmark, and Germany participated SME dominance: All bidders and winners are SMEs Oncology focus: All products are essential cancer treatments For suppliers, this procurement highlights the importance of: Competitive pricing: Price is the sole criterion Regulatory compliance: Quality is assured through regulatory approvals European presence: Ability to supply across borders Supply reliability: Dependable delivery to hospital pharmacies Supplier Takeaways Offer competitive pricing—price is the sole criterion (100%) Ensure regulatory compliance for pharmaceutical products Develop European presence to participate in cross-border tenders Demonstrate reliable supply capabilities Monitor Amgros and other central purchasing bodies for future opportunities Consider SME status as an advantage in this market Key Takeaways Amgros awarded a DKK 690 million pharmaceutical framework 4 lots: Bortezomib (FrostPharma), Thalidomid (Zentiva), Lenalidomid (Sun Pharma), Pomalidomid (Devatis) Evaluation: Price only (100%) 2-6 bids per lot Duration: 1 Jan 2027 – 31 Dec 2028 (+ 12-month option) All winners are SMEs Suppliers from Sweden, Denmark, and Germany No EU funding used Conclusion This pharmaceutical framework represents a significant procurement for Danish hospital pharmacies, securing essential medicines for cancer treatment from January 2027. By awarding four lots to specialised suppliers—FrostPharma, Zentiva, Sun Pharma, and Devatis—Amgros ensures that Danish hospitals have access to Bortezomib, Thalidomid, Lenalidomid, and Pomalidomid at competitive prices. The price-only evaluation (100%) drives strong competition, with 2-6 bids per lot. The participation of suppliers from Sweden, Denmark, and Germany demonstrates the European nature of the pharmaceutical market. All winners are SMEs, reflecting the structure of the generic pharmaceutical supply chain. As Amgros continues to conduct pharmaceutical procurements for the Danish hospital sector, further opportunities will arise for suppliers with competitive pricing and reliable supply capabilities. Frequently Asked Questions Q: What is Amgros? Ans: A Danish joint procurement body (interessentskab) owned by the five Danish regions, responsible for purchasing pharmaceuticals and medical equipment for the hospital sector. Q: What is the value of the framework? Ans: DKK 690,479,003 (approximately €92.5 million). Q: Who are the winners? Ans: FrostPharma AB (Lot 1), Zentiva Denmark ApS (Lot 2), Sun Pharmaceuticals Germany GmbH (Lot 3), Devatis GmbH (Lot 4). Q: What products are covered? Ans: Bortezomib, Thalidomid, Lenalidomid, and Pomalidomid. Q: What were the evaluation criteria? Ans: Price only (100%). Q: How long is the contract? Ans: 1 January 2027 – 31 December 2028 (with a 12-month extension option). Q: How many bids were received? Ans: 2-6 bids per lot. Q: Is this contract funded by the EU? Ans: No, the procurement is not financed with EU funds. Source: EU Official Journal, Contract Award Notice 560003-2026, OJ S 154/2026, published 12 August 2026. body { font-family: sans-serif; margin: 20px; } table { border-collapse: collapse; width: 100%; margin: 15px 0; } th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; } th { background-color: #f2f2f2; } ul { padding-left: 20px; } h2 { margin-top: 30px; } h3 { margin-top: 20px; }
View Details
Best-AV wins DKK 54M AV/videoconferencing equipment framework
11 Aug 2026
Region Hovedstaden (Capital Region of Denmark) has awarded a framework agreement for AV and videoconference equipment to Best-AV A/S. The framework, valued at up to DKK 54 million (approximately €7.2 million), covers the purchase and support of standard and complex AV solutions for the region's healthcare facilities across the Capital Region and Bornholm. Introduction Effective communication is essential in modern healthcare. AV and videoconference equipment enables remote consultations, telemedicine, staff training, and administrative meetings across the Capital Region of Denmark's extensive healthcare network. Region Hovedstaden has awarded a framework agreement for AV and videoconference equipment to Best-AV A/S. The framework, valued at up to DKK 54 million (approximately €7.2 million), covers the purchase and support of standard and complex AV solutions. The contract is for an initial period of 48 months with options for three 12-month extensions. This procurement ensures that healthcare facilities across the Capital Region and Bornholm have access to modern, reliable AV and videoconference equipment to support patient care and staff collaboration. Why This Contract Matters AV and videoconference equipment is increasingly essential for modern healthcare delivery, enabling telemedicine, remote consultations, and staff collaboration across geographically dispersed sites. This contract matters because it: Supports healthcare communication: Enables telemedicine and remote consultations Covers the entire region: Serves healthcare facilities across the Capital Region and Bornholm Significant value: Framework valued at up to DKK 54 million (€7.2 million) Quality-focused: Quality weighting of 60%, price 40% Comprehensive scope: Covers both standard and complex AV solutions Long-term commitment: 48 months with three 12-month extensions SME supplier: Best-AV A/S is a small Danish company Contract Timeline Contract award notice published: 11 August 2026 (OJ S 153/2026) Previous notice referenced: a5eaf322-ba2d-41c3-a5f1-666fd426f49e-01 Winner chosen: 23 June 2026 Contract concluded: 10 August 2026 Coverage start date: Not specified Coverage end date: Up to 48 months + 3 x 12-month extensions (max 84 months) Contract Overview Region Hovedstaden conducted an open procedure for this procurement. The framework covers the purchase and support of AV and videoconference equipment for the region's Center for IT and Medical Technology. Key features include: Single lot: AV and videoconference equipment Duration: 48 months + 3 x 12-month extension options (max 84 months) Value: DKK 54,000,000 (maximum), with re-estimated value of DKK 1,540,000 Evaluation: Quality (60%) and Price (40%) Winner: Best-AV A/S (small Danish company) No subcontracting: Best-AV will deliver without subcontracting Coverage: Nordsjælland, Byen København, Københavns omegn, Bornholm Key Contract Details Detail Information Contracting authority Region Hovedstaden (Capital Region of Denmark) Winning bidder Best-AV A/S Contract subject AV and videoconference equipment (CPV 32232000, 32321200, 72600000) Procedure type Open procedure Legal basis EU Directive 2014/24/EU Maximum value (DKK) DKK 54,000,000.00 (approx. €7.2 million) Re-estimated value (DKK) DKK 1,540,000.00 Contract duration 48 months + 3 x 12-month extensions (max 84 months) Bids received 4 EU funding None Covered by GPA Yes Evaluation criteria Quality (60%), Price (40%) Subcontracting No Supplier size Small enterprise (SME) Geographic coverage Capital Region of Denmark and Bornholm Project Scope The framework covers the purchase and support of AV and videoconference equipment for the Capital Region of Denmark's healthcare facilities. Equipment Categories Videoconference equipment: Complete videoconferencing solutions Audio-visual equipment: AV equipment for meeting and treatment rooms Sound-reproduction apparatus: Speakers and audio systems Microphones and loudspeakers: Audio capture and reproduction Cameras: Video capture equipment Computer screens and consoles: Display and control equipment Computer support and consultancy services: Support and consultancy for AV systems Scope of Solutions Standard rooms: Standard AV and videoconference solutions Complex rooms: More complex AV solutions for specialised spaces Complete solutions: Full AV system installations Single products: Supplementary individual products Geographic Coverage Nordsjælland: North Zealand Byen København: Copenhagen City Københavns omegn: Copenhagen Surroundings Bornholm: Bornholm Island About the Contracting Authority Region Hovedstaden (Capital Region of Denmark) is a regional authority responsible for healthcare services in the Capital Region of Denmark, including hospitals, healthcare centres, and public health services. The region's Center for IT and Medical Technology (CIMT) manages IT and medical technology procurement, including AV and videoconference equipment for healthcare facilities. About the Winning Company Best-AV A/S is a small Danish company based in Glostrup, near Copenhagen. The company specialises in AV and videoconference solutions for public sector clients, including healthcare institutions. Best-AV's experience in delivering AV solutions to the healthcare sector made it a strong candidate for this framework. The company's winning bid of DKK 1,540,000 was the successful tender among four bids received. Procurement Analysis Procedure: An open procedure was used, allowing any interested economic operator to submit a tender. Competition: Four bids were received, representing healthy competition in the AV equipment market. Evaluation criteria: Quality (60%) and Price (40%). The heavy weighting on quality reflects the importance of reliability, compatibility, and support for healthcare AV systems. SME participation: The winner is a small enterprise, demonstrating that SMEs can compete effectively in public procurement. No subcontracting: Best-AV will deliver without subcontracting, indicating in-house capability. Long duration: 48 months with three 12-month extensions (up to 84 months), providing long-term stability. Options: Includes options for transition to Region Øst and time-based services. Additional Procurement Facts The contract is covered by the WTO's Government Procurement Agreement (GPA). No EU funds were used for this procurement. The procurement was not accelerated. No dynamic purchasing system was used. Framework agreement with reopening of competition was used. Four bids were received, all electronically. The winner is a small Danish company (SME). No subcontracting was declared by the winner. Disputes or review requests fall to Klagenævnet for Udbud (Danish Complaints Board for Procurement). The procurement includes sanctions against Russian entities (EU Regulation 2022/576). Market & Industry Perspective The Danish AV and videoconference equipment market is served by a mix of large international suppliers and smaller specialised Danish companies. The healthcare sector has specific requirements for reliability, security, and integration with existing systems. Key trends in this market include: Telemedicine: Growing demand for videoconference equipment in healthcare Integration: AV systems must integrate with existing IT infrastructure Security: Healthcare AV systems must meet strict data protection requirements Support: Reliable support and maintenance are essential SME participation: Smaller companies can compete effectively The 60% quality weighting reflects the importance of reliability and support for healthcare AV systems. Economic Significance At up to DKK 54 million (approximately €7.2 million), this framework represents a significant investment in AV and videoconference equipment for the Capital Region's healthcare facilities. The contract supports: Healthcare communication: Enables telemedicine and remote consultations Staff collaboration: Supports meetings and collaboration across sites Patient care: Improves access to specialist consultations SME growth: Supports a small Danish company Future Procurement Opportunities With the framework now in place, future opportunities include: Contract extensions: Up to three 12-month extensions Transition to Region Øst: Option for transition to Region Øst Other Danish regions: Similar frameworks may be conducted by other Danish regions Related services: Time-based services and support Opportunities for Suppliers While this framework is awarded, future opportunities exist for AV and videoconference suppliers: Subcontracting: Suppliers may find subcontracting opportunities with Best-AV Other Danish regions: Similar frameworks from other regions Time-based services: Option for time-based services Related technologies: Emerging AV and videoconference technologies What Businesses Should Watch Other Danish regions' procurement notices for AV equipment Emerging AV and videoconference technologies Changes to Danish healthcare procurement regulations EU sanctions affecting Russian suppliers Telemedicine and healthcare technology trends DenmarkTender Procurement Intelligence This AV and videoconference equipment framework is a significant procurement for the Capital Region of Denmark. Several features stand out: Quality focus: Quality weighting of 60% reflects the importance of reliability and support SME success: Best-AV, a small company, won the framework Long duration: Up to 84 months provides long-term stability Healthcare focus: Equipment supports telemedicine and healthcare communication Geographic coverage: Covers the entire Capital Region and Bornholm The selection of Best-AV demonstrates that SMEs can compete effectively for large public contracts when they offer quality and value. For suppliers, this procurement highlights the importance of: Quality: Demonstrating quality and support (60% of evaluation) Competitive pricing: Price accounts for 40% of evaluation Healthcare expertise: Experience with healthcare AV solutions Regional presence: Being established in Denmark Supplier Takeaways Demonstrate quality and support—quality accounts for 60% of evaluation Offer competitive pricing—price accounts for 40% Develop expertise in healthcare AV and videoconference solutions Establish regional presence in Denmark Monitor other Danish regions for similar opportunities Consider partnerships with larger suppliers for complex solutions Key Takeaways Capital Region of Denmark awarded an AV and videoconference framework to Best-AV A/S Value: Up to DKK 54 million (approx. €7.2 million) Duration: 48 months + 3 x 12-month extensions (max 84 months) Evaluation: Quality (60%), Price (40%) 4 bids received Winner is a small Danish company (SME) No subcontracting Geographic coverage: Capital Region of Denmark and Bornholm Conclusion This AV and videoconference equipment framework represents a significant investment in the Capital Region of Denmark's healthcare communication infrastructure. By awarding the contract to Best-AV A/S, a small Danish company, the region demonstrates its commitment to supporting local SMEs while securing high-quality equipment and support. The 60% quality weighting reflects the importance of reliability, compatibility, and support for healthcare AV systems, which are essential for telemedicine, remote consultations, and staff collaboration. As the region continues to invest in digital healthcare solutions, this framework will support the delivery of modern, efficient healthcare services across the Capital Region and Bornholm. Frequently Asked Questions Q: What is Region Hovedstaden? Ans: The Capital Region of Denmark, a regional authority responsible for healthcare services in the Copenhagen metropolitan area and Bornholm. Q: What is the value of the framework? Ans: Up to DKK 54,000,000 (approximately €7.2 million), with a re-estimated value of DKK 1,540,000. Q: Who won the contract? Ans: Best-AV A/S, a small Danish company based in Glostrup. Q: What equipment is covered? Ans: AV and videoconference equipment, including cameras, microphones, speakers, screens, and related services. Q: What were the evaluation criteria? Ans: Quality (60%) and Price (40%). Q: How long is the contract? Ans: 48 months with three 12-month extension options (up to 84 months total). Q: How many bids were received? Ans: Four bids were received. Q: Is this contract funded by the EU? Ans: No, the procurement is not financed with EU funds. Source: EU Official Journal, Contract Award Notice 555745-2026, OJ S 153/2026, published 11 August 2026. body { font-family: sans-serif; margin: 20px; } table { border-collapse: collapse; width: 100%; margin: 15px 0; } th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; } th { background-color: #f2f2f2; } ul { padding-left: 20px; } h2 { margin-top: 30px; } h3 { margin-top: 20px; }
View Details